Elderly Persons with ICU-Acquired Weakness: The Potential Role for β-Hydroxy-β-Methylbutyrate (HMB) Supplementation?

Journal of Parenteral and Enteral Nutrition

Volumn 38, Issue 5, 2014, Pages 567-575

  Rahman, Adam ^a   Wilund, Kenneth ^b   Fitschen, Peter J ^b   Jeejeebhoy, Khursheed ^c,d   Agarwala, Ravi ^e   Drover, John W ^f   Mourtzakis, Marina ^g  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f QUEEN S UNIVERSITY   (Canada)

^g UNIVERSITY OF WATERLOO   (Canada)

Author keywords

adult; critical care; nutrition

Indexed keywords

BETA HYDROXY BETA METHYLBUTYRATE; BUTYRIC ACID DERIVATIVE; UNCLASSIFIED DRUG; BETA-HYDROXYISOVALERIC ACID; VALERIC ACID DERIVATIVE;

AGED; CRITICALLY ILL PATIENT; DIET SUPPLEMENTATION; HUMAN; INTENSIVE CARE UNIT; INTENSIVE CARE UNIT ACQUIRED WEAKNESS; LEAN BODY WEIGHT; MEDICAL RESEARCH; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE WEAKNESS; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; AGING; DIET THERAPY; DRUG EFFECTS; FEMALE; INTENSIVE CARE; MALE; MUSCLE ATROPHY; MUSCLE STRENGTH; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; QUALITY OF LIFE; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; CRITICAL CARE; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MUSCLE STRENGTH; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; QUALITY OF LIFE; TREATMENT OUTCOME; VALERATES;

EID: 84904756679     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607113502545     Document Type: Review

References (56)

1. Young G, Hammond R. A stronger approach to weakness in the intensive care unit. Crit Care. 2004 ; 8 (6). 416-418 (Pubitemid 40073669)
2. Dalton R, Tripathi R, Abel E, et al. Polyneuropathy and myopathy in the elderly. HSR Proc Intensive Care Cardiovasc Anesth. 2012 ; 4 (1). 15-19
3. Latronico N, Bolton C. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011 ; 10 (10). 931-941
4. Visser L. Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis. Eur J Neurol. 2006 ; 13 (11). 1203-1212 (Pubitemid 44581466)
5. Fitschen P, Wilson G, Wilson J, Wilund K. Efficacy of β-hydroxy-β-methylbutyrate supplementation in elderly and clinical populations. Nutrition. 2013 ; 29 (1). 29-36
6. Reid M, Allard-Gould P. Malnutrition and the critically ill elderly patient. Crit Care Nurs Clin North Am. 2004 ; 16 (4). 531-536 (Pubitemid 39574893)
7. Paddon-Jones D Report of the 110th Abbott Nutrition Research Conference: Selected Summaries. Gussler J, ed. Columbus, OH: Abbott Nutrition ; 9-14.
8. Garnacho-Montero J, Madrazo-Osuna J, García-Garmendia J, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med. 2001 ; 27 (8). 1288-1296 (Pubitemid 32758926)
9. Rubenfeld G. Interventions to improve long-term outcomes after critical illness. Curr Opin Crit Care. 2007 ; 13 (5). 476-481 (Pubitemid 47357444)
10. Nguyen Y, Angus D, Boumendil A, Guidet B. The challenge of admitting the very elderly to intensive care. Ann Intensive Care. 2011 ; 1: 29
11. Schweickert W, Hall J. ICU-acquired weakness. Chest. 2007 ; 131 (5). 1541-1549 (Pubitemid 46762364)
12. Bolton C, Gilbert J, Hahn A, Sibbald W. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 1984 ; 47 (11). 1223-1231 (Pubitemid 15204538)
13. Friedrich O, Fink R, Hund E. Understanding critical illness myopathy: approaching the pathomechanism. J Nutr. 2005 ; 135 (7). 1813S - 1817S (Pubitemid 40980740)
14. Friedrich O, Hund E, Weber C, Hacke W, Fink R. Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skeletal muscle. J Neurol. 2004 ; 251 (1). 53-65 (Pubitemid 38210490)
15. Zink W, Kollmar R, Schwab S. Critical illness polyneuropathy and myopathy in the intensive care unit. Nat Rev Neurol. 2009 ; 5 (7). 372-379
16. Hough C, Steinberg K, Thompson B, Rubenfeld G, Hudson L. Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med. 2009 ; 35 (1). 63-68
17. Bercker S, Weber-Carstens S, Deja M, et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med. 2005 ; 33: 711-715
18. Herridge M, Cheung A, Tansey C, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003 ; 348 (8). 683-693 (Pubitemid 36237037)
19. Stevens R, Marshall S, Cornblath D, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med. 2009 ; 37 (10). S299 - S308
20. Marcus R, Addison O, Dibble L, et al. Intramuscular adipose tissue, sarcopenia, and mobility function in older individuals. J Aging Res. 2012 ; 2012: 629637
21. Thomas D. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr. 2007 ; 4: 389-399 (Pubitemid 47091483)
22. Wolfe R. The underappreciated role of muscle in health and disease. Am J Clin Nutr. 2006 ; 84 (3). 475-482 (Pubitemid 44713395)
23. Zeiderman M, McMahon M. The role of objective measurement of skeletal muscle function in the pre-operative patient. Clin Nutr. 1989 ; 8 (3). 161-166 (Pubitemid 19167698)
24. Hadley J, Hinds C. Anabolic strategies in critical illness. Curr Opin Pharmacol. 2002 ; 2 (6). 700-707 (Pubitemid 35476923)
25. Slone D. Nutritional support of the critically ill and injured patient. Crit Care Clin. 2004 ; 20: 135-157 (Pubitemid 38167297)
26. Artinian V, Krayem H, DiGiovine B. Effects of early enteral feeding on the outcome of critically ill mechanically ventilated medical patients. Chest. 2006 ; 129 (4). 960-967
27. Jones N, Heyland D. Pharmaconutrition: a new emerging paradigm. Curr Opin Gastroenterol. 2008 ; 24: 215-222 (Pubitemid 351322790)
28. Hsieh L, Chien S, Huang M, Tseng H, Chang C. Anti-inflammatory and anticatabolic effects of short-term beta-hydroxy-beta-methylbutyrate supplementation on chronic obstructive pulmonary disease patients in intensive care unit. Asia Pac J Clin Nutr. 2006 ; 15: 544-550 (Pubitemid 44905134)
29. Wilson G, Wilson J, Mannine A. Effects of beta-hydroxy-beta- methylbutyrate (HMB) on exercise performance and body composition across varying levels of age, sex, and training experience: a review. Nutr Metab (Lond). 2008 ; 5: 1
30. Nissen S, Sharp R. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol. 2003 ; 94 (2). 651-659 (Pubitemid 36158243)
31. Norton L, Layman D. Leucine regulates translation initiation of protein synthesis in skeletal muscle after exercise. J Nutr. 2006 ; 136 (2). 533S - 537S (Pubitemid 43228315)
32. Rieu I, Balage M, Sornet C, et al. Leucine supplementation improves muscle protein synthesis in elderly men independently of hyperaminoacidaemia. J Physiol. 2006 ; 575: 305-315 (Pubitemid 44182713)
33. Wilkinson D, Hossain T, Hill D, et al. Effects of leucine and its metabolite, β-hydroxy-β-methylbutyrate (HMB) on human skeletal muscle protein metabolism. J Physiol. 2013 ; 591 (pt 11). 2911-2923
34. Portal S, Eliakim A, Nemet D, Halevy O, Zadik Z. Effect of HMB supplementation on body composition, fitness, hormonal profile and muscle damage indices. J Pediatr Endocrinol Metab. 2012 ; 23 (7). 641-650
35. Smith H, Mukerji P, Tisdale M. Attenuation of proteasome-induced proteolysis in skeletal muscle by β-hydroxy-β-methylbutyrate in cancer-induced muscle loss. Cancer Res. 2005 ; 65 (1). 277-283 (Pubitemid 40070819)
36. Wilson J, Lowery R, Joy J, et al. Hydroxy-β-methylbutyrate free acid reduces markers of exercise-induced muscle damage and improves recovery in resistance-trained men. Br J Nutr. 2013 ; 110 (3). 538-544
37. Wilson J, Fitschen P, Campbell B, et al. International Society of Sports Nutrition position stand: beta-hydroxy-beta-methylbutyrate (HMB). Int Soc Sports Nutr. 2013 ; 10 (1). 6
38. Hsieh L, Chow C, Chang W, Liu T, Chang C. Effect of beta-hydroxy-beta- methylbutyrate on protein metabolism in bed-ridden elderly receiving tube feeding. Asia Pac J Clin Nutr. 2010 ; 19 (2). 200-208
39. Vukovich M, Stubbs N, Bohlken R. Body composition in 70-year-old adults responds to dietary beta-hydroxy-beta-methylbutyrate similarly to that of young adults. J Nutr. 2001 ; 131: 2049-2052 (Pubitemid 32661078)
40. Flakoll P, Sharp R, Baier S, et al. Effect of beta-hydroxy-beta- methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women. Nutrition. 2004 ; 20: 445-451 (Pubitemid 38501798)
41. Baier S, Johannsen D, Abumrad N, et al. Year-long changes in protein metabolism in elderly men and women supplemented with a nutrition cocktail of beta-hydroxy-beta-methylbutyrate (HMB), L-arginine, and L-lysin. JPEN J Parenter Enteral Nutr. 2009 ; 33: 71-82
42. Kuhls D, Rathmacher J, Musngi M, et al. Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients. J Trauma. 2007 ; 62: 125-131 (Pubitemid 46102842)
43. Ezzell L, Jensen G. Malnutrition in chronic obstructive pulmonary disease. Am J Clin Nutr. 2000 ; 72 (6). 1415-1416
44. Levine S, Nguyen T, Taylor N, et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008 ; 358 (13). 1327-1335 (Pubitemid 351468409)
45. May PE, Barber A, D'Olimpio JT, Hourihane A, Abumrad NN. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg. 2002 ; 183 (4). 471-9 (Pubitemid 34442515)
46. Clark R, Feleke G, Din M, et al. Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study. JPEN J Parenter Enteral Nutr. 2000 ; 24: 133-139
47. Marcora S, Lemmey A, Maddison P. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial. Clin Nutr. 2005 ; 24: 442-454 (Pubitemid 40668432)
48. Clements RH, Saraf N, Kakade M, Yellumahanthi K, White M, Hackett JA. Nutritional effect of oral supplement enriched in beta-hydroxy-beta- methylbutyrate, glutamine and arginine on resting metabolic rate after laparoscopic gastric bypass. Surg Endosc. 2011 ; 25 (5). 1376-82
49. Heyland D, Dhaliwal R, Drover JW, et al. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr. 2003 ; 5 (27). 355-373 (Pubitemid 37022781)
50. Rice T, Wheeler A, Thompson B, et al. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. JAMA. 2012 ; 22;307 (8). 795-803
51. Casaer M, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011 ; 6 (365). 506-517
52. Heidegger C, Berger M, Graf S, et al. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet. 2013 ; 381 (9864). 385-393
53. Heyland D, Dhaliwal R, Jiang X, Day A. Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool. Crit Care. 2011 ; 15 (6). R268
54. Heyland D, Cahill N, Day A. Optimal amount of calories for critically ill patients: depends on how you slice the cake!. Crit Care Med. 2011 ; 12: 2619-2626
55. Allingstrup M, Esmailzadeh N, Wilkens A, et al. Provision of protein and energy in relation to measured requirements in intensive care patients. Clin Nutr. 2012 ; 31 (4). 462-468
56. Wu T, Huang J, Lin C. Effects of fluid retention on the measurement of body composition using bioelectric impedance. J Formos Med Assoc. 1994 ; 93 (11-12). 939-943